Literature DB >> 22668950

Remote sensing of HIV care programmes using centrally collected laboratory results: can we monitor ART programme effectiveness?

Carl Morrow1, Alison Munro, Marisa Wilke, Ruth Stark, Robin Wood.   

Abstract

AIMS: We describe a monitoring system at population level of patients on antiretroviral therapy (ART) using centrally collected laboratory data. We demonstrate an analogous process of remote sensing using a large set of laboratory results and illustrate the tremendous density of information stored. We moved from an individual to a community view of ART rollout, similar to remote sensing used in the earth and biological sciences when the spatial scale of the investigation is too large to be performed at ground level.
METHODS: This was a retrospective cohort study of patients from January 2004 to June 2011. A total of 188 759 individual laboratory results representing 26 445 patients were analysed for average CD4 and viral load by year.
RESULTS: The data showed an increasing state of health of the population and allowed for hypothesis generation when the trends did not follow expected paths.
CONCLUSION: In this analysis we moved away from individual-centred data to population-level data in order to assess ART programme performance. Routine patient-monitoring data had great utility in assessment of population health. These methods are useful in monitoring and evaluation and effectiveness studies as they are easy to collect, reliable (not requiring much human matching or interventions) and scalable from a single clinic to an entire population. The larger the sample size, the more reliable the results, as confounders (such as incorrectly identified transfers out, lost-to-follow-up patients and transfers in) would be removed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22668950      PMCID: PMC3816247          DOI: 10.7196/samj.5625

Source DB:  PubMed          Journal:  S Afr Med J


  11 in total

1.  Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?

Authors:  Stephen D Lawn; Landon Myer; Robin Wood
Journal:  Clin Infect Dis       Date:  2005-12-01       Impact factor: 9.079

2.  Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model.

Authors:  Anthony D Harries; Patrick Gomani; Roger Teck; Olga Ascurra de Teck; Edwin Bakali; Rony Zachariah; Edwin Libamba; Andrina Mwansambo; Felix Salaniponi; Rex Mpazanje
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-12       Impact factor: 2.184

3.  Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa.

Authors:  David Coetzee; Katherine Hilderbrand; Andrew Boulle; Beverley Draper; Fareed Abdullah; Eric Goemaere
Journal:  Bull World Health Organ       Date:  2005-07       Impact factor: 9.408

Review 4.  Challenges in implementing CD4 testing in resource-limited settings.

Authors:  Trevor Peter; Anne Badrichani; Emily Wu; Richard Freeman; Bekezela Ncube; Fabiana Ariki; Jennifer Daily; Yoko Shimada; Maurine Murtagh
Journal:  Cytometry B Clin Cytom       Date:  2008       Impact factor: 3.058

5.  Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco.

Authors:  Moupali Das; Priscilla Lee Chu; Glenn-Milo Santos; Susan Scheer; Eric Vittinghoff; Willi McFarland; Grant N Colfax
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

6.  Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon.

Authors:  Patrice Tchendjou; Chantal Same-Ekobo; Annie Nga; Mathurin Tejiokem; Anfumbom Kfutwah; Anne Njom Nlend; Landry Tsague; Anne Cécile Bissek; Daniel Ekoa; Joanna Orne-Gliemann; Dominique Rousset; Régis Pouillot; François Dabis
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

7.  Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa.

Authors:  Rishikesh P Dalal; Catherine Macphail; Mmabatho Mqhayi; Jeff Wing; Charles Feldman; Matthew F Chersich; Willem D F Venter
Journal:  J Acquir Immune Defic Syndr       Date:  2008-01-01       Impact factor: 3.731

8.  Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.

Authors:  Stephen D Lawn; Landon Myer; David Edwards; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

9.  Establishment of reference CD4+ T cell values for adult Indian population.

Authors:  Madhuri R Thakar; Philip R Abraham; Sunil Arora; Pachamuthu Balakrishnan; Bhaswati Bandyopadhyay; Ameeta A Joshi; K Rekha Devi; Ravi Vasanthapuram; Madhu Vajpayee; Anita Desai; Janardhanan Mohanakrishnan; Kanwar Narain; Krishnangshu Ray; Shilpa S Patil; Ravinder Singh; Anuj Singla; Ramesh S Paranjape
Journal:  AIDS Res Ther       Date:  2011-10-03       Impact factor: 2.250

Review 10.  Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.

Authors:  Sandra Mathis; Bettina Khanlari; Federico Pulido; Mauro Schechter; Eugenia Negredo; Mark Nelson; Pietro Vernazza; Pedro Cahn; Jean-Luc Meynard; Jose Arribas; Heiner C Bucher
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

View more
  1 in total

1.  The survival benefits of antiretroviral therapy in South Africa.

Authors:  Michael D April; Robin Wood; Bethany K Berkowitz; A David Paltiel; Xavier Anglaret; Elena Losina; Kenneth A Freedberg; Rochelle P Walensky
Journal:  J Infect Dis       Date:  2013-12-03       Impact factor: 5.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.